List view / Grid view

GBI Research



Head and neck cancer market fertile for investment

8 March 2017 | By GBI Research

A substantial number of first-in-class products in the head and neck cancer pipeline will reach the market over the coming decade, which could potentially transform the clinical and commercial landscape, according to business intelligence firm GBI Research.